JSP Pharmaceutical Manufacturing Thailand Public : Report on use of proceed from IPO ended 30 June 2022
July 19, 2022 at 06:54 am
Share
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
No. JPCS-22/011
19 July 2022
RE:
Report on use of proceed from IPO ended 30 June 2022
TO:
Director and Manager, The Stock Exchange of Thailand
On 21, 25 and 26 October 2021, JSP Pharmaceutical Manufacturing (Thailand) PCL. ("the Company") issued 115,000,000 newly ordinary shares by Initial Public Offering ("IPO") with issue price at THB 7.00 per share. Later, the Company registered ordinary shares to the Market of Alternative Investment ("mai") on 2 November 2021. In this regard, the Company received proceed from IPO totalled THB 805.00 million. After deducting underwriting fees and other related costs of this issuance, the Company had net proceed amounting to THB 755.38 million.
The Company would like to report the use of IPO proceed ended 30 June 2022 as follow:
Remaining
proceed as of
Actual use of
Remaining
Estimated use
31 December
proceed ended
proceed as of
Use of proceed objectives
of proceed
2021
30 June 2022
30 June 2022
(Unit : THB million)
1.
New product development
20.00
20.00
8.52
11.48
2.
Develop, present and PR
200.00
180.18
14.02
166.16
advertisements
3.
Renovate and expand factories
294.35
67.47
226.88
298.00
4.
Repayment of loans from
100.00
11.92
11.92
-
financial institutions
5.
Working capital for operations
137.38
107.71
38.62
69.09
Total
755.38
614.16
140.55
473.61
Please be informed accordingly
(
)
(
)
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
(Mr. Kriangkrai Rungruangthaweekul)
Vice President of Finance
Investor Relations
Tel 064 479 1691
Emailir@jsppharma.com
Attachments
Original Link
Original Document
Permalink
Disclaimer
JSP Pharmaceutical Manufacturing Thailand pcl published this content on 19 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 July 2022 10:53:08 UTC.
JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customerâs brand name (OEM), as well as under the Companyâs brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customersâ trademark (OEM) and the seller of the products under the Companyâs trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Companyâs subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC CO., LTD. 
